Interval (weeks) | Incident SN | r1
| R1
|
---|
0 – 2
| 6 | 0.06 | 0.06 |
2 – 4
| 10 | 0.10 | 0.15 |
4 – 12
| 16 | 0.14 | 0.27 |
12 – 24
| 4 | 0.04 | 0.30 |
- r1 is calculated as the ratio of the number of individuals who developed neuropathic symptoms to the number of patients at risk during the interval.
- R1 is the cumulative rate of development of neuropathic symptoms by end of the interval.
- For further analysis, 2 individuals with incident neuropathic symptoms were excluded due to detectable HIV-1 viral loads at week 24.